SEC Filing Analysis: Werewolf Therapeutics, Inc. (HOWL)

Executive Summary

• Trading Significance: Low
• Key Takeaway: A director indirectly sold approximately $62,000 worth of stock through multiple transactions executed under a pre-established Rule 10b5-1 trading plan.
• Market Impact: The transaction's small size and pre-scheduled nature suggest a neutral market impact.

Company Information

Field	Value
Company	Werewolf Therapeutics, Inc.
Ticker Symbol	HOWL
CIK	0001785530
Industry	PHARMACEUTICAL PREPARATIONS

Insider Information

Field	Value
Name	EVNIN LUKE
CIK	0001134657
Title/Position	null
Relationship	Director

Transaction Details

Field	Value
Form Type	4
Transaction Date	2026-01-13 to 2026-01-15
Transaction Code	S (Sale)
Security Type	Common Stock
Shares Involved	111,227
Price Per Share	~$0.56 (Weighted Avg)
Total Value	$61,787.17
Shares Owned After	2,198,642
Ownership Type	Indirect

Financial Impact Assessment

Transaction Materiality

Metric	Value
Transaction Value	$61,787.17
% of Market Cap	0.15%
Shares Transacted	111,227
% of Shares Outstanding	Not Available
Post-Transaction Ownership	2,198,642 shares
Materiality Assessment	Low

Impact Evaluation

• Market Cap Context: For a nano-cap company with a $40 million market capitalization, this $62k sale represents just 0.15% of its total value. This is not considered a material event.
• Ownership Concentration: The sale of 111,227 shares constitutes a minor reduction (approx. 4.8%) of the insider's total indirect holdings. The insider retains a substantial position of over 2.1 million shares after the sale.
• Transaction Significance: The significance is low due to the small transaction size relative to the company's market cap and the fact that it was executed under a Rule 10b5-1 plan, which removes the element of discretionary timing.

Market Impact Analysis

Stock Impact Prediction

• Direction: Neutral
• Reasoning: The sales are minor in value and were pre-scheduled via a 10b5-1 plan established in September 2025. This indicates the transactions are likely for personal financial planning or portfolio management rather than a reaction to recent company developments.

Volume & Sentiment

• Expected Volume Impact: Minimal. The daily transaction volumes are small and unlikely to significantly impact trading patterns.
• Sentiment Indicator: Neutral. The market generally discounts the signaling value of sales made under 10b5-1 plans.

Additional Context

Special Circumstances

• 10b5-1 Plan: As disclosed in Footnote 1, all transactions were executed pursuant to a Rule 10b5-1 trading plan dated September 24, 2025. This is a critical piece of context, indicating the sales were not based on immediate, non-public information.
• Indirect Ownership: The shares are held indirectly by several MPM-affiliated venture capital funds where the reporting person is a managing member or director.